OXFORD, England, February 11th 2015.
PharmaVentures is pleased to announce that it is to increase its life science presence in North America by establishing a new base in Boston, MA. Starting this month Dr Adrian Dawkes, VP, will be dividing his time between the USA and the UK.
This announcement follows a record year for mandates in M&A and licensing for PharmaVentures.
Dr. Fintan Walton, CEO, PharmaVentures, commented: “With America still the biggest market for healthcare and with Boston leading life science innovation it makes immense sense for us to have one of our most experienced deal makers on the ground. Increasingly our clients need access to the opportunities that America offers and Adrian’s contacts and experience will be of great value to them.”
Dr Adrian Dawkes, VP, added “With a growing number of pharma clients and deals in America, including those involving major pharmaceutical companies such as Pfizer and Merck and leading life science companies, we would like to provide support and interact directly with leading innovators and healthcare companies in The USA as well as worldwide.”
Should you wish to meet up with Adrian to discuss your needs and our capabilities please drop him an email or give him a call on +44 7931 428487.
adrian@pharmaventures.com
– Ends-